From short-acting to long-acting formulations, the wide range of GLP- 1 receptor agonists available provides physicians with numerous options to tailor treatment to each patient's needs
Early Human Evidence for Hair and Skin Outcomes Skin outcomes have more direct human evidence than hair outcomes
Tumor stiffness measured by quantitative and qualitative shear wave elastography of breast cancer
BPC 157 therapy also, on its own, counteracts isoniazid (GABA synthesis inhibitor)-, picrotoxin (non-completive channel blocker for GABAA receptors (GABAARs) chloride channels)- [58], and bicuculline (completive antagonists of GABAARs)-convulsions [15]
doi:10.3390/cosmetics2030236 Pickart L, Vasquez-Soltero JM, Margolina A
While other publications from the group remain intact, the retraction introduces uncertainty about the reliability of some mechanistic claims and demands particular caution in interpreting the overall evidence base